Professor John Forrester
MD FRCSE FRCSG FRCOphth
Professor Forrester received his MD, ChB from Glasgow University, Scotland in 1970. In 1980 he received his MD also from the University of Glasgow. Between 1979-1984 he was Consultant Ophthalmologist/Clinical Lecturer in Ophthalmology at Glasgow University. In 1984 he was appointed to his current post, Cockburn Professor of Ophthalmology University of Aberdeen/Honorary Consultant Ophthalmologist, NHS Grampian.
He has over the years received 16 awards and Visiting Professorships including the London Hospital Prize for Original Research in Ophthalmology in 1977, the Duke Elder Medal and the Ida Mann Medal in 1991. He received the Spinoza Professorship in Amsterdam in 1998 and the Kimura Lectureship as Visiting Professor (UCSF) University of California, San Francisco in 2004.
His main areas of research are Diabetic Retinopathy, Angiogenesis, Endothelial Cell Function, Ocular Immunology, Uveitis, Autoimmune Disease, Imaging in Ophthalmology, Wound Healing and Corneal Transplantation and has published over 260 papers.
He is a Fellow of the Royal College of Surgeons of Edinburgh and Glasgow, Royal College of Ophthalmologists, Physicians of Edinburgh, Academy of Medical Sciences and the Royal Society of Edinburgh.
He was Chairman of the RCOphth Medical Ophthalmology Training Sub-Committee and the RCOphth Diabetic Retinopathy Guidelines Committee and a member of the MRC Advisory Board. He was previously Editor-in-Chief of the British Journal of Ophthalmology 1992-2000. He is currently an Editorial Board member of the British Journal of Ophthalmology, European Journal of Ophthalmology and Current Eye Research.
Page 1 of 23 Results 1 to 10 of 222
Immune Privilege Furnishes a Niche for Latent InfectionFrontiers in Ophthalmology, vol. 2, 869046Contributions to Journals: Articles
A Role for Folate in Microbiome-Linked Control of AutoimmunityJournal of Immunology Research, vol. 2021, 9998200Contributions to Journals: Review articles
Low-dose 2-Deoxy Glucose Stabilises Tolerogenic Dendritic Cells and Generates Potent in vivo Immunosuppressive EffectsCellular and Molecular Life Sciences, vol. 78, no. 6, pp. 2857-2876Contributions to Journals: Articles
Immune Privilege: the Microbiome and UveitisFrontiers in Immunology, vol. 11, 608337Contributions to Journals: Articles
The Role of Inflammation in Diabetic RetinopathyFrontiers in Immunology, vol. 11, no. 20, pp. 10319-10329Contributions to Journals: Articles
Treatment with FoxP3+ Antigen-Experienced T Regulatory Cells Arrests Progressive Retinal Damage in a Spontaneous Model of UveitisFrontiers in Immunology, vol. 11, pp. 1-17Contributions to Journals: Articles
Activation of dendritic cells by crosslinked collagen hydrogels (artificial corneas) varies with their compositionJournal of Tissue Engineering and Regenerative Medicine, vol. 13, no. 9, pp. 1528-1543Contributions to Journals: Articles
TGF‐β1‐activated type 2 dendritic cells promote wound healing and induce fibroblasts to express tenascin c following corneal full‐thickness hydrogel transplantationJournal of Tissue Engineering and Regenerative Medicine, vol. 13, no. 9, pp. 1507-1517Contributions to Journals: Articles
Retinoic acid‐induced autoantigen‐specific type 1 regulatory T cells suppress autoimmunityEMBO reports, vol. 20, no. 3, e47121Contributions to Journals: Articles
Transmission Electron Microscopy Data on drusen-like deposits in the retinal degeneration sTg-IRBP: HEL mouse modelData in brief, vol. 22, pp. 140-144Contributions to Journals: Articles